-
Mashup Score: 1
Skip Nav Destination August 18, 2022 Prophylactic tranexamic acid (TXA) did not decrease World Health Organization (WHO) grade ≥2 bleeding incidence or rates of platelet or red blood cell (RBC) transfusions in patients with thrombocytopenia…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Chemotherapy-Free Regimens Change the Game - 2 year(s) ago
The number of drugs and regimens that fall under the umbrella term of “chemotherapy-free” regimens continues to grow.
Source: bloodcancerstoday.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Gunther Koehne, MD, PhD, discusses his hopes for future advances for patients with hematologic malignancies.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Hematologic complications of immune checkpoint inhibitors - 2 year(s) ago
This Review Series, edited by past Associate Editor Catherine Bollard, looks at the role of immunotherapy in nonmalignant hematologic diseases. These 3 state-of
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Survivors of Hematologic Malignancies With Higher BMI Exhibit Increased Insulin Resistance | ASH Clinical News | American Society of Hematology - 2 year(s) ago
Skip Nav Destination April 27, 2022 Survivors of hematologic malignances were found to have disproportionately greater insulin resistance with increasing body mass index (BMI) compared to those with high…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Early Research on Targeting the Sugar Coat of Tumors Cells Expands to Hematologic Malignancies - 2 year(s) ago
In an interview with Targeted Oncology, Robert Sackstein, MD, discussed ongoing research around the strategy of targeting the sugar coat of cancer cells to potentially aid in cancer treatment, particularly in hematologic malignancies.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Given the ubiquity of leukopenia and sinopulmonary infections in childhood, differentiating patients with inborn errors of immunity (IEI) from otherwise healthy patients can be challenging. The diagnostic complexity is further exacerbated in disorders with wide phenotypic variability such as WHIM (warts, hypogammaglobulinemia, infections and myelokathexis) syndrome. However, utilizing a…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 2Non-Tryptase Urinary and Hematologic Biomarkers of Mast Cell Expansion and Mast Cell Activation: Status 2022 - 2 year(s) ago
Quantitation of urinary metabolites of histamine, prostaglandin D2 and leukotriene E4 can fill the gap in our current efforts to improve diagnosis and management of symptomatic patients with systemic mastocytosis, and/or mast cell activation syndrome, Additionally, patients symptomatic due to mast cell activation but who do not meet all the criteria for mast cell activation syndrome also can have…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 1Critical illness in patients with hematologic malignancy: a population-based cohort study - PubMed - 3 year(s) ago
Critical illness in patients with a newly diagnosed hematologic malignancy is frequent, occurring early after diagnosis. Certain baseline characteristics can help identify those patients at the highest risk.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 1Epitranscriptomics in Hematopoiesis and Hematologic Malignancies - 3 year(s) ago
Since the 1960s, a large number of chemical modifications have been identified in RNA molecules, establishing the RNA epigenetics field named “epitranscriptomics.” These chemical marks participate in several RNA metabolic processes; however, the biological relevance of many of these modifications and the many enzymes involved in their function is not completely understood. Emerging knowledge of…
Source: Blood Cancer DiscoveryCategories: Future of Medicine, Latest HeadlinesTweet-
Our article about #Epitranscriptomics #RNAmodifications in #Hematopoiesis #Leukemia #Lymphoma included in Highlights Collection of Blood Cancer Discovery @BCD_AACR @AACR, selection of papers of broadest interest across and beyond #hematologic malignancies https://t.co/ID75UXTLAM https://t.co/EZBtcifAdP
-
#Prophylactic #TXA did not decrease WHO grade ≥2 bleeding incidence or rates of platelet or RBC transfusions in patients with #thrombocytopenia associated with treatment of #hematologic #malignancy, according to a @BloodJournal study https://t.co/YAYzv5XC3a